Cargando…
Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients
AIM: To assess liver fibrosis (LF) in hepatitis C virus (HCV) and alcoholic liver disease (ALD), estimate health outcomes and costs of new noninvasive testing strategies METHODS: A Markov model was developed to simulate LF progression in HCV and ALD for a cohort of 40-year-old men with abnormal leve...
Autores principales: | Soto, Marcelo, Sampietro-Colom, Laura, Lasalvia, Luis, Mira, Aurea, Jiménez, Wladimiro, Navasa, Miquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423053/ https://www.ncbi.nlm.nih.gov/pubmed/28533673 http://dx.doi.org/10.3748/wjg.v23.i17.3163 |
Ejemplares similares
-
On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019) -
Mortality and rebleeding following variceal haemorrhage in liver cirrhosis and periportal fibrosis
por: Mohammed, Sara Elfadil Abbas, et al.
Publicado: (2016) -
Non-invasive assessment of liver fibrosis using two-dimensional shear wave elastography in patients with autoimmune liver diseases
por: Zeng, Jie, et al.
Publicado: (2017) -
Ohio solid organ transplantation consortium criteria for liver transplantation in patients with alcoholic liver disease
por: Hajifathalian, Kaveh, et al.
Publicado: (2016) -
Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study
por: Makker, Jasbir, et al.
Publicado: (2021)